In our previous study, we showed that RIP2 expression increased in gliomas; additionally, findings from in vitro studies indicated that RIP2 could activate the NF‐κB and p38 signaling pathways and subsequently influence the biological behavior of malignant gliomas.23 This evidence concerns the gene RIPK2 and central nervous system cancer.